BioTech and Health Policy - Connected Health Pulse

Income Inequality is Fostering Mis-Trust, the Edelman 2020 Trust Barometer Observes

Health Populi

JANUARY 22, 2020

In health care, these would be our honest-and-ethical front-line workers — nurses, physicians, and pharmacists, the latest Gallup Poll on the question learned (described here in Health Populi). where private sector organizations began to more visibly take on public health objectives and missions.

BioTech

BioTech Primary Care Public Health Mental health

Will Technology Cure Americans’ Health Care System Ills? Considering Google and Ascension Health’s Data Deal

Health Populi

NOVEMBER 12, 2019

What’s underneath that macro “healthcare” index number of 67 is a precipitous decline in the past year for Americans’ trust in hospitals, compared with biotech, pharma, consumer healthcare, and even health insurance — all of which grew in trust between 2018 and 2019, but not so with the hospital segment of U.S.

BioTech

BioTech Medical Billing HIPAA Health Information

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

JANUARY 18, 2019

As the Harvard Chan-POLITICO study points out, prescription drug costs are top-of-mind for health consumers in America. First, a Wall Street Journal profile of Bluebird Bio , a biotech firm that plans to sell gene-replacement therapy extending annual payments to patients based on whether the drug is effective.

BioTech

BioTech Medicare Medical Billing Patient Experience

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

What Your Financial Statements Are Telling You—And How to Listen!

MORE WEBINARS

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Health Populi

MARCH 6, 2019

The Kaiser Family Foundation has been tracking this topic for a few years, and this month, their March 2019 Health Tracking Poll shows vast majorities of Democrats, Independents and Republicans all share these sentiments. There’s little Americans, by political party, agree upon in 2019.

Pharmaceuticals

Pharmaceuticals Medicare Life Science BioTech

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

OCTOBER 28, 2019

rank prescription drugs, lab tests, emergency room visits, dental and vision care, preventive services, chronic disease management and mental health care as the “most essential” health care services, according to the 2019 Survey of America’s Patients conducted by The Physicians Foundation. People in the U.S.

Pharmaceuticals

Pharmaceuticals Medical Billing Medicare Mental health

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Health Populi

MARCH 11, 2021

The coolest thing in health policy in the 21st century!! ” Amitabh Chandra gave the opening context-setting talk about the effects of health care cost-sharing on patients-as-consumers. Kavita Patel to assert in the first panel of the day that, “2713 is my favorite number.”

Health Policy

Health Policy Medicare Pharmaceuticals Life Science

Prescription Drugs in the Pandemic, Year 2: Pricing Rx and Going Direct-to-Consumer

Health Populi

AUGUST 16, 2021

There is one health care public policy issue that unites U.S. voters across political party: that is the consumer-facing costs of prescription drugs.

Pharmaceuticals

Pharmaceuticals Telehealth BioTech Mental health

Americans Across Political Party Worry About Prescription Drug Prices – Especially to Deal with COVID-19

Health Populi

JUNE 18, 2020

In today’s pharma/biotech market, the “specialty” label is given to many therapies: for products addressing rare diseases, risk-management, and above all, high cost drugs. The phrase “specialty drugs” originated in the 1970s in the advent of injectable and infusion therapies.

BioTech

BioTech Medicare Life Science Telehealth

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Health Populi

JUNE 24, 2021

We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies? While telehealth and virtual care stood up quickly in 2020, questions remain about how it will/can persist in terms of funding, regulation, and business models.

BioTech

BioTech Pharmaceuticals Public Health Telehealth

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

JULY 1, 2019

When this occurred, it didn’t cause more than a ripple of interest outside biotech. To address that challenge, in 2017 PLM secured a $100 million (controlling interest) investment from iCarbonX , a Chinese company that is amassing patient data to discover cures for disease. But the U.S. citizens’ personal data.

Pharmaceuticals

Pharmaceuticals HIPAA BioTech Patient Experience

Consumers Consider Cost When They Think About Medical Innovation

Health Populi

JULY 10, 2018

Health Populi’s Hot Points: Americans draw a very big distinction between biotech and pharma when it comes to trust, this year’s Edelman Trust Barometer found. Biotech = innovation; Pharma = cost- and profit-seeking, was the rough arithmetic I intuited from the survey findings, which I discussed here in Health Populi.

BioTech

BioTech Medical Billing Life Science Pharmaceuticals

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Health Populi

MAY 4, 2023

It’s a volume speaking volumes on the current picture of prescribed meds, spending and revenues, health care utilization trends, and a forecast looking out to 2027. Reviewing the annual 2023 report from the IQVIA Institute for Human Data Science discussing The Use of Medicines in the U.S.

Public Health

Public Health Mental health Life Science Telehealth

Two-Thirds of Americans Say Healthcare Doesn’t Work Well, in RealClear Politics Poll

Health Populi

MAY 19, 2019

.” Health Populi’s Hot Points: RealClear asked people to consult their forecasting tea leaves to consider which industries and organizations would improve the quality of health care for Americans 20 years into the future.

Life Science

Life Science BioTech Medicare Medical Billing

What Do Democrats and Republicans Agree On? Allowing Government & Business to Negotiate Lower Rx Prices

Health Populi

JUNE 3, 2021

So you might think that the most important public priority for Congress might have something to do with COVID-19, vaccines, or health insurance coverage. People living in the U.S. have weathered over fifteen months of life-shifts for work, school, prayer, fitness, and social lives.

Medicare

Medicare Life Science BioTech Pharmaceuticals

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Health Populi

MAY 8, 2019

. “A therapy is useless if no one can afford it,” asserted Cathryn Donaldson from AHIP, the health insurance advocacy group, quoted in the story. ” The politics of prescription drug pricing will continue to be personal for health care voters, I forecast in my own scenarios looking toward not 2023 — but 2020.

Medicare

Medicare BioTech Pharmaceuticals Mental health

The Remarkable Rise of Pharma’s Reputation in the Pandemic

Health Populi

FEBRUARY 22, 2021

consumers trusted the biotech health industry segment compared with the pharmaceutical segment. Right now they’re very science- and research-forward versus very business-forward.”. That logic was bolstered by a finding in the 2018 Edelman Trust Barometer finding more U.S. Why was this the case?

Life Science

Life Science Pharmaceuticals Public Health BioTech

Connected Health Pulse

Income Inequality is Fostering Mis-Trust, the Edelman 2020 Trust Barometer Observes

Will Technology Cure Americans’ Health Care System Ills? Considering Google and Ascension Health’s Data Deal

Webinars

Trending Sources

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Webinars

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Prescription Drugs in the Pandemic, Year 2: Pricing Rx and Going Direct-to-Consumer

Americans Across Political Party Worry About Prescription Drug Prices – Especially to Deal with COVID-19

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Consumers Consider Cost When They Think About Medical Innovation

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Two-Thirds of Americans Say Healthcare Doesn’t Work Well, in RealClear Politics Poll

What Do Democrats and Republicans Agree On? Allowing Government & Business to Negotiate Lower Rx Prices

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

The Remarkable Rise of Pharma’s Reputation in the Pandemic

Stay Connected